| Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia. | |
| | |
MedLine Citation:
|
PMID: 3451884 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The role of bradycardia in reducing exercise-induced ischaemia and wall dysfunction was examined in dogs with single vessel chronic coronary artery stenosis created using an ameroid constrictor. Treadmill exercise produced significant regional myocardial ischaemia (blood flow measured using microspheres) and contractile dysfunction (systolic wall thickening measured with sonomicrometers). Dogs were initially studied during a control run before and during a second identical run after administration of the cardioselective beta-adrenergic blocker atenolol, which improved regional ischaemic function from 4.4 +/- 3.7% to 8.5 +/- 2.8% and subendocardial perfusion from 0.43 +/- 0.23 to 0.55 +/- 0.29 ml min-1 g-1. In another group of dogs during a run with atenolol, the heart rate was paced to match the rate observed in the control run. During the atenolol run with pacing, all beneficial effects of atenolol observed at the reduced exercise heart rate were lost. A third group of dogs received the bradycardic agent UL-FS 49 (1.0 mg kg-1, i.v.) prior to exercise. UL-FS 49 produced a heart rate reduction during exercise from 230 +/- 19 to 139 +/- 10 beats min-1; this was associated with an increase in systolic wall thickening from 9.3 +/- 5.0% (during the control run) to 21.5 +/- 8.4%, thereby eliminating the exercise-induced contractile dysfunction. Transmural myocardial blood flow per beat to the poststenotic myocardium was improved significantly from 4.8 X 10(-3) +/- 1.9 X 10(-3) ml beat-1 to 9.8 X 10(-3) +/- 1.7 X 10(-3). Atrial pacing to match heart rate to the control exercise rate during the UL-FS 49 run did not eliminate all of the improvement in systolic wall thickening.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
B D Guth; G Heusch; R Seitelberger; M Matsuzaki; J Ross |
Related Documents
:
|
11689734 - Stroke volume does not plateau during graded exercise in elite male distance runners. 16195994 - Mechanical comparison of barefoot and shod running. 20213264 - Cardiac troponin t elevations, using highly sensitive assay, in recreational running de... 9885094 - Aetiology of running-related gastrointestinal dysfunction. how far is the finishing line? 15912284 - Investigating gender-related construct-irrelevant components of scores on the written a... 8964734 - Effect of marathon run on serum igf-i and igf-binding protein 1 and 3 levels. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: European heart journal Volume: 8 Suppl L ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1987 Dec |
Date Detail:
|
Created Date: 1988-07-19 Completed Date: 1988-07-19 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 61-8 Citation Subset: IM |
Affiliation:
|
Seaweed Canyon Cardiovascular Laboratory, University of California San Diego, La Jolla 92093. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Arrhythmia Agents / therapeutic use* Atenolol / therapeutic use* Benzazepines / therapeutic use* Coronary Circulation / drug effects Coronary Disease / drug therapy*, etiology Dogs Heart Rate / drug effects* Myocardial Contraction / drug effects* Physical Exertion* |
| Grant Support | |
ID/Acronym/Agency:
|
HL-17682/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 0/Benzazepines; 29122-68-7/Atenolol; 85175-67-3/zatebradine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of specific bradycardic agents on exercise-induced regional myocardial dysfunction in dogs.
Next Document: Effects of bradycardic agents on ischaemic myocardium and perfusion in anesthetized dogs.